Backbone rigidity and static presentation of guanidinium groups increases cellular uptake of arginine-rich cell-penetrating peptides

Nature Communications

Volumn 2, Issue 1, 2011, Pages

  Lättig Tünnemann, Gisela ^a,b   Prinz, Manuel ^c   Hoffmann, Daniel ^c   Behlke, Joachim ^a   Palm Apergi, Caroline ^d   Morano, Ingo ^a   Herce, Henry D ^e   Cardoso, M Cristina ^a,e  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d STOCKHOLM UNIVERSITY   (Sweden)

^e DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CELL PENETRATING PEPTIDE; GUANIDINE;

ANIMAL CELL; ARTICLE; CELL KINETICS; CELL MEMBRANE; CELL STRUCTURE; CYCLIZATION; ENDOCYTOSIS; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; ULTRACENTRIFUGATION; ANIMAL; CELL LINE; CELLS; CHEMICAL STRUCTURE; CHEMISTRY; KINETICS; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ARGININE; BIOLOGICAL TRANSPORT; CELL LINE; CELL MEMBRANE; CELL-PENETRATING PEPTIDES; CELLS; GUANIDINE; KINETICS; MICE; MOLECULAR STRUCTURE;

EID: 84877755819     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms1459     Document Type: Article

References (31)

1. Frankel, A. D. & Pabo, C. O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55, 1189-1193 (1988). (Pubitemid 19020071)
2. Green, M. & Loewenstein, P. M. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55, 1179-1188 (1988). (Pubitemid 19020070)
3. Rothbard, J. B., Jessop, T. C., Lewis, R. S., Murray, B. A. & Wender, P. A. Role of membrane potential and hydrogen bonding in the mechanism of translocationof guanidinium-rich peptides into cells. J. Am. Chem. Soc. 126, 9506-9507 (2004). (Pubitemid 39031015)
4. Tünnemann, G. et al. Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells. Faseb J. 20, 1775-1784 (2006). (Pubitemid 44933791)
5. Ter-Avetisyan, G. et al. Cell entry of arginine-rich peptides is independent of endocytosis. J. Biol. Chem. 284, 3370-3378 (2009).
6. Tünnemann, G. et al. Live-cell analysis of cell penetration ability and toxicity of oligo-arginines. J. Pept. Sci. 14, 469-476 (2008). (Pubitemid 351540908)
7. Fretz, M. M. et al. Temperature-, concentration- and cholesterol- dependent translocation of L- and D-octa-arginine across the plasma and nuclear membrane of CD34+ leukaemia cells. Biochem. J. 403, 335-342 (2007). (Pubitemid 46596590)
8. Herce, H. D. & Garcia, A. E. Molecular dynamics simulations suggest a mechanism for translocation of the HIV-1 TAT peptide across lipid membranes. Proc. Natl Acad. Sci. USA 104, 20805-20810 (2007).
9. Herce, H. D. et al. Arginine-rich peptides destabilize the plasma membrane, consistent with a pore formation translocation mechanism of cell-penetrating peptides. Biophys. J. 97, 1917-1925 (2009).
10. Palm-Apergi, C., Lorents, A., Padari, K., Pooga, M. & Hallbrink, M. The membrane repair response masks membrane disturbances caused by cellpenetrating peptide uptake. Faseb J. 23, 214-223 (2009).
11. Tünnemann, G. & Cardoso, M. C. in Membrane-Active Peptides: Methods and Results on Structure and Function Vol. 9. (ed. M. Castanho) 331-362 (IUL Publishers, 2009).
12. Fawell, S. et al. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl Acad. Sci. USA 91, 664-668 (1994). (Pubitemid 24041462)
13. Vives, E., Brodin, P. & Lebleu, B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-16017 (1997). (Pubitemid 27265584)
14. Futaki, S. et al. Arginine-rich peptides. An abundant source of membranepermeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276, 5836-5840 (2001).
15. Martin, R. M., Tünnemann, G., Leonhardt, H. & Cardoso, M. C. Nucleolar marker for living cells. Histochem. Cell Biol. 127, 243-251 (2007).
16. Ho, A., Schwarze, S. R., Mermelstein, S. J., Waksman, G. & Dowdy, S. F. Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res. 61, 474-477 (2001). (Pubitemid 32128600)
17. Choi, M. et al. Inhibition of NF-kappaB by a TAT-NEMO-binding domain peptide accelerates constitutive apoptosis and abrogates LPS-delayed neutrophil apoptosis. Blood 102, 2259-2267 (2003). (Pubitemid 37122408)
18. Tünnemann, G., Karczewski, P., Haase, H., Cardoso, M. C. & Morano, I. Modulation of muscle contraction by a cell-permeable peptide. J. Mol. Med. 85, 1405-1412 (2007). (Pubitemid 350234094)
19. Fischer, P. M. et al. Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin. J. Pept. Res. 55, 163-172 (2000). (Pubitemid 30079933)
20. Wender, P. A. et al. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl Acad. Sci. USA 97, 13003-13008 (2000).
21. Duchardt, F., Fotin-Mleczek, M., Schwarz, H., Fischer, R. & Brock, R. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 8, 848-866 (2007). (Pubitemid 46971632)
22. Afonin, S. et al. The cell-penetrating peptide TAT(48-60) induces a nonlamellar phase in DMPC membranes. Chemphyschem 7, 2134-2142 (2006).
23. Ziegler, A., Nervi, P., Durrenberger, M. & Seelig, J. The cationic cellpenetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence. Biochemistry 44, 138-148 (2005). (Pubitemid 40095715)
24. Mishra, A., Gordon, V. D., Yang, L., Coridan, R. & Wong, G. C. HIV TAT forms pores in membranes by inducing saddle-splay curvature: potential role of bidentate hydrogen bonding. Angew. Chem. Int. Ed. 47, 2986-2989 (2008).
25. Rothbard, J. B. et al. Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake. J. Med. Chem. 45, 3612-3618 (2002). (Pubitemid 34856101)
26. Luedtke, N. W., Carmichael, P. & Tor, Y. Cellular uptake of aminoglycosides, guanidinoglycosides, and poly-arginine. J. Am. Chem. Soc. 125, 12374-12375 (2003). (Pubitemid 37254733)
27. Chung, H. H. et al. Dendritic oligoguanidines as intracellular translocators. Biopolymers 76, 83-96 (2004).
28. Rabut, G. & Ellenberg, J. Automatic real-time three-dimensional cell tracking by fluorescence microscopy. J. Microsc. 216, 131-137 (2004). (Pubitemid 39469786)
29. Behlke, J. & Ristau, O. A new approximate whole boundary solution of the Lamm differential equation for the analysis of sedimentation velocity experiments. Biophys. Chem. 95, 59-68 (2002). (Pubitemid 34203676)
30. Oncley, J. L. Evidence from physical chemistry regarding the size and shape of proteins from ultracentrifugation, diffusion, viscosity, dielectric dispersion and double refraction of flow. Ann. NY Acad. Sci. 41, 121-156 (1941).
31. Van Der Spoel, D. et al. GROMACS: fast, flexible, and free. J. Comput. Chem. 26, 1701-1718 (2005). (Pubitemid 43076182)